Tradestie Institutional Equity Comparison Engine

ABCL vs GAINL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GAINL Overall Edge

GAINL Captures Institutional Edge (2โ€“2 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Gladstone Investment Corporation 8.00% Notes due 2028 (GAINL) driven by superior Growth & Margin, Options & Structure while ABCL counters with relative strength in Valuation, Momentum & Technical. Fundamentally, ABCL trades at 27.6x Forward P/E with -298.0% operating margin (+18.8% YoY revenue) versus GAINL at N/M Forward P/E and 42.5% operating margin (+68.4% YoY). In options structure, ABCL sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro) against GAINL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ABCL
ABCL 27.6x vs GAINL N/M Fwd P/E
Growth & Margin Winner GAINL
Op Margin -298.0% vs 42.5% ยท YoY +18.8% vs +68.4%
Momentum & Technical Winner ABCL
1Y +168.4% vs -2.3% ยท 52W Pos 57% vs 9%
Options & Structure Winner GAINL
BREAKDOWN (32nd %ile IV) vs UNCLASSIFIED (N/A IV)
ABCL NASDAQ
AbCellera Biologics Inc. Common Shares
Pharmaceutical Preparations
$9.69
-7.45% 1D
Market Cap $3.4B
1M Return -14.78%
1Y Return +168.42%
Forward P/E 27.6x
Unified AI Score
57.1 / 100 HOLD
Tech 33.0 Fund 54.0 Flow 70.0 Mom 64.0
GAINL NASDAQ
Gladstone Investment Corporation 8.00% Notes due 2028
Institutional Equity
$25.21
+0.13% 1D
Market Cap $358.3M
1M Return -1.91%
1Y Return -2.32%
Forward P/E N/M
Unified AI Score
59.2 / 100 HOLD
Tech 60.0 Fund 52.0 Flow 50.0 Mom 48.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABCL +168.42% GAINL -2.32% Spread: +3.29 pp (GAINL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABCL TTM Op. Margin: -298.0% GAINL TTM Op. Margin: 42.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABCL vs GAINL. Trailing 12-month operating profitability (ABCL -298.0% vs GAINL 42.5%) and valuation multiples (ABCL 27.6x vs GAINL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABCL (4) vs GAINL (6)
Institutional Metric ABCL GAINL Criterion Row Winner
Market Capitalization Scale $3.4B $358.3M Larger Scale ABCL
Trailing P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Forward P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Revenue Growth (YoY) Growth +18.8% +68.4% Higher Growth GAINL
Operating Margin (TTM) Profitability -298.0% 42.5% Higher Margin GAINL
Net Profit Margin Profitability -218.6% 140.1% Higher Margin GAINL
Return on Equity (ROE) Capital Efficiency -14.6% 22.9% Higher ROE GAINL
52-Week Range Position Momentum 57% ($3โ€“$15) 9% ($25โ€“$26) Stronger Trend ABCL
Beta / 30D Volatility Risk Regime 2.32ฮฒ ยท 85% Vol 0.02ฮฒ ยท 2% Vol Lower Realized Risk GAINL
Unified Institutional Score Composite Signal 57.1 / 100 (HOLD) 59.2 / 100 (HOLD) Higher Composite GAINL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABCL vs GAINL Buy Guide
ABCL BREAKDOWN
38d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ABCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GAINL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GAINL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABCL nor GAINL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.